Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Sanguineti

Showing results (151-160 of 199) with videos related to

Pageof 20
Sort By:
Frontiers in Oncology|August 28, 2020
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation EffectsAndrea Bresolin, Elisabetta Garibaldi, Adriana Faiella, et al.
Cancers|July 2, 2021
Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and RadiotherapyFernando Munoz, Giuseppe Sanguineti, Andrea Bresolin, et al.
Cancer Science|May 8, 2024
HER2 mutation as an emerging target in advanced breast cancerGiulia Bon, Francesca Sofia Di Lisa, Lorena Filomeno, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 29, 2020
Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of RomeFabio Pelle, Sonia Cappelli, Franco Graziano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell CarcinomaFederica Ganci, Claudio Pulito, Sara Valsoni, et al.
Plos One|March 2, 2016
DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory AnalysisPatrizia Vici, Simonetta Buglioni, Domenico Sergi, et al.
Journal of Cellular Physiology|May 18, 2016
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT TrialLaura Pizzuti, Maddalena Barba, Diana Giannarelli, et al.
Scientific Reports|April 15, 2021
Validation of a biomarker tool capable of measuring the absorbed dose soon after exposure to ionizing radiationAnna Giovanetti, Raffaella Marconi, Noha Awad, et al.
Current Oncology (Toronto, Ont.)|February 23, 2024
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRTAngelo Maggio, Tiziana Rancati, Marco Gatti, et al.
Oncoimmunology|July 30, 2016
Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironmentSimonetta Buglioni, Patrizia Vici, Domenico Sergi, et al.
Pageof 20

Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
Frontiers in Oncology|August 28, 2020
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation EffectsAndrea Bresolin, Elisabetta Garibaldi, Adriana Faiella, et al.
Cancers|July 2, 2021
Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and RadiotherapyFernando Munoz, Giuseppe Sanguineti, Andrea Bresolin, et al.
Cancer Science|May 8, 2024
HER2 mutation as an emerging target in advanced breast cancerGiulia Bon, Francesca Sofia Di Lisa, Lorena Filomeno, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 29, 2020
Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of RomeFabio Pelle, Sonia Cappelli, Franco Graziano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell CarcinomaFederica Ganci, Claudio Pulito, Sara Valsoni, et al.
Plos One|March 2, 2016
DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory AnalysisPatrizia Vici, Simonetta Buglioni, Domenico Sergi, et al.
Journal of Cellular Physiology|May 18, 2016
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT TrialLaura Pizzuti, Maddalena Barba, Diana Giannarelli, et al.
Scientific Reports|April 15, 2021
Validation of a biomarker tool capable of measuring the absorbed dose soon after exposure to ionizing radiationAnna Giovanetti, Raffaella Marconi, Noha Awad, et al.
Current Oncology (Toronto, Ont.)|February 23, 2024
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRTAngelo Maggio, Tiziana Rancati, Marco Gatti, et al.
Oncoimmunology|July 30, 2016
Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironmentSimonetta Buglioni, Patrizia Vici, Domenico Sergi, et al.
Pageof 20